Health IT Analytics January 28, 2021
Jessica Kent

The genetic database includes nearly 12,000 pieces of information that researchers and providers can use to develop precision medicine therapies for COVID-19.

Researchers from the University of Alabama at Birmingham have created a genetic database designed to help advance precision medicine treatments for COVID-19.

The database, called PAGER-CoV-2, includes 11,835 pathways, annotated gene lists, and gene signatures (PAGs). Pathways are the roadmap that describes how genes are turned on and off and how they establish connections with each other. Annotated gene lists are empirical information that researchers collect from experiments or literature, while gene lists help researchers understand how a certain cell type behaves under different conditions.

A gene signature is a unique pattern of gene expression within a cell...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Public Health / COVID
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article